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SIDE E F F E C T S OF TREATMENT WITH THYROSTATICS 
V. Nikolova, L . Koeva 
Department of Endocrinology and Gastroenterology, 
Medical University of Varna, Varna 
The authors report their results from the study of 118 patients with thyrotoxico­
sis treated in Clinic of Endocrinology, Department of Endocrinology and Gastroenter­
ology in 1996-1997. The treatment with thyrostatics has a number of side effects, most 
common of which are leukopenia, allergic reactions, and liver disorders. The compli­
cations depend on the dose of the drug, the duration of its application, the preliminary 
leukocyte count, and the state of the liver. The treatment with Propycil shows less 
frequent side effects than that with Metizol. With L-Thyroxin included in the therapy 
the goitrogenic effects and drug-induced hypothyroidism are prevented. Propycil (Solvay 
Pharma) is preferable because of its quicker initial and clinical effect in the treatment 
of thyrotoxic crisis, in pregnancy, and preoperative preparation. 
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Thyrotoxicosis is one of the wide­
spread endocrine diseases. Its treatment 
takes time, requires extensive medical ex­
perience and cooperation by the patient. 
The doses of the treatment, its duration, 
side effects and necessity of radical 
behaviour are still under discussion (1,3)-
Our goal was to study the side effects of 
the treatment of thyrotoxicosis with 
thyrostatics. 
MATERIAL AND METHODS 
A total of 118 patients with thy­
rotoxicosis^^ 
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crinology, Department of Endocrinology 
and Gastroenterology, Medical University 
of Varna in 1996-1997 were analyzed. 
They were 20 malea and 98 females. 
Male:female ratio was of 1:4,9. Predomi­
nant age of the male patients was between 
45-49 years and of female ones - 26-59 
years. The diagnosis was determined 
based on clinical picture, tests of total Тз 
and T 4 , TSM, ultrasound of thyroid gland, 
scintigraphy, and in some patients - on 
TRM-test. The treatment was undertaken 
with preparations of the Methylmer-
captoimidazol group - Metizol and 
Propylthiouracil. In most cases the start­
ing dose of Metizol was 30 (40) mg and 
of Propycil (Solvay Pharma) - 200 (300) 
mg daily. With Metizol were treated 101 
patients and with Propycil 50 ones (17 of 
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them from the beginning and 33 as a result 
of side effects to Metizol). Of the 118 pa­
tients, 98 suffered from Grave's disease, 
18 from Mashitoxicosis, and 12 from toxic 
nodular goitre. 
RESULTS AND DISCUSSION 
After defining the diagnosis we 
started the treatment with Metizol in 
most cases. Initial reaction to this medi­
cine was observed after 6-7 days and 
clinical one after 10 days. Seventeen 
cases were treated with Propycil since 
the beginning. In these cases the initial 
reaction started on the second day and 
after a week an objective improvement 
of symptoms was registered. Based on 
these observations we prefer Propycil 
in the treatment of patients with thyro­
toxic crisis, during preoperative prepa­
ration, and in pregnancy. 
It is known that, in pregnancy, 
Metizol crosses the placenta more readily 
than Propycil (2). Allergic reaction was 
observed in 13 patients treated with 
Metizol and only in one treated with 
Propycil. In 3 cases it was registered at 
the 7 t h day of the treatment, in 4 - after the 
20 t h day, and in the rest patients consider­
ably later - after 2-3 months. After switch­
ing-over to Propycil the allergic symptoms 
occurred in 6 cases. In other 6 ones the 
full treatment was conducted after de­
creasing the dose, inclusion of antialler­
gic drugs, and in 2 cases - of corticos­
teroids. 
In one patient only the allergic 
symptoms continued. The patient was pre­
pared with Sol. Lugoli and operated un­
der application of beta-blockers, corticos­
teroids, and antiallergic drugs. At the mo­
ment she is in a very good state 6 months 
after operation. In some cases when a 
dose of 2 tablets of Propycil daily was 
reached we returned to Metizol again 
which did not triggered an allergic reac­
tion (low dose). 
Twenty-six patients developed a 
reduced leukocytes number under ЗЛО9 
and in some case it was under 2.109 when 
treated with Metizol in a dose of 30 mg 
per day. Because of this fact in 12 out of 
27 cases the treatment was changed to 
Propycil but in 8 ones the number of leu­
kocytes remained still low. Leukopenia 
was treated with Vitamin Вб, which led to 
stabilization of the leukocyte number in 6 
patients. 
For the rest patients we had to 
prescribe corticosteroids in low doses. In 
the beginning of the treatment with 
thyrostatics some cases only showed a 
tendency to a leukopenia. The moderate 
decrease of the dose was enough to avoid 
this side effect. 
In the first days of the treatment 
we observed an increased level of tran­
saminases in 8 cases treated with 
Metizol and in one case treated with 
Propycil. In three of them there were 
data of previous viral hepatitis. 
In other 4 patients transamisane 
levels increased before the treatment with 
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statics began. Two patients were in­
vestigated in the Clinic of Gastroenterol­
ogy for liver pathology and it was found 
out that they were cases of hepatitis reac­
tive to thyrotoxicosis. In all of the above 
mentioned cases a treatment with Propycil 
and hepato-protective therapy was cho­
sen. Only one of them still could not over­
come the liver problems and developed 
persisting hepatitis. 
Some other less frequent side ef­
fects observed during the treatment with 
thyrostatics were the following: stomach 
pain in 5 cases and bone pains in two fe­
male patients without osteoporosis. 
Goitrogenic effects or drug-in­
duced hypothyroidism were observed ex­
tremely rare because of L-Thyroxin (Ber-
lin-Chemie) addition to the treatment. 
CONCLUSION 
We can conclude that the treat­
ment with thyrostatics has a number of side 
effects, most common of which are leu­
kopenia, allergic reaction, and liver disor­
ders. The side effects depend on the dose 
of the drug, the duration of its application, 
the preliminary leukocyte number and the 
condition of the liver. 
The treatment with Propycil shows 
less frequent side effects than the treat­
ment with Metizol. When L-Thyroxin is 
included in the therapy, the goitrogenic ef­
fects and iatrogenic hypothyroidism are 
prevented. Propycil is preferred for its 
quicker initial and clinical effect in the treat­
ment of thyrotoxic crisis, during pregnancy, 
and for preoperative patient's preparation. 
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Странични прояви при лечение с тиреостатични средства 
В. Николова, Л. Коева 
Катедра по ендокринология и гастроентерология, 
Медицински университет-Варна 
Резюме: Авторите съобщават за проучване на 118 болни с тиреотоксикоза, лекувани 
в Клиниката по ендокринология на Катедрата по ендокринология и гастроентерология 
през 1996-1997 г. След лечение с тиреостатици са налице редица странични ефекти, 
най-чести от които са левкоцитопенията, следвана от алергичните реакции и 
чернодробните нарушения. Усложненията зависят от дозата и продължителността на 
лечението, предварителното ниво на левкоцитите и състоянието на черния дроб. При 
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лечението с Propycil се наблюдават по-рядко странични ефекти, отколкото при това с 
Metizol. Предимството на препарата Propycil (Solvay Pharma) се състои в по-бързия 
начален и клиничен ефект, поради което той трябва да се прилага при тиреотоксични 
кризи, бременност и предоперативна подготовка. 
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